As the largest resource of information specific to women's brain health, we are sure you will find what you are looking for, and promise that you will discover new information.
Published on: August 14, 2011
by Press TV
A study of over 80,000 women, aged 54 to 79 found those with a history of depression had a 29 percent higher risk of stroke than non-depressed counterparts.
A six-year follow-up also showed that women who took antidepressants, particularly selective serotonin reuptake inhibitors, or SSRIs (such as Prozac or Zoloft), were 39 percent more likely to experience a stroke, says the report published in the journal Stroke.
“Although we found women who took antidepressants were at higher risk, I don’t have anything to indicate it’s because of the medications,” noted co-author Kathryn Rexrod who suggests that women on medication treatment might suffer from more severe symptoms than those who don’t opt for the pills.
“I don’t think the medications themselves are the primary cause of the risk. This study does not suggest that people should stop their medications to reduce the risk of stroke,” she further emphasized.
The findings also showed that depressed women were more likely to have stroke risk factors such as being single, smoker and physically inactive. Moreover, they had a higher body mass index (BMI) and more coexisting conditions such as high blood pressure, heart disease and diabetes and possibly more inflammation risk.
“Depression can prevent individuals from controlling other medical problems such as diabetes and hypertension, from taking medications regularly or pursuing other healthy lifestyle measures such as exercise,” Rexrode noted.
“Regardless of the mechanism, recognizing that depressed individuals may be at a higher risk of stroke may help the physician focus on not only treating the depression, but treating stroke risk factors such as hypertension, diabetes and elevated cholesterol as well as addressing lifestyle behaviors such as smoking and exercise,” An Pan, the other co-author suggested.
A new comprehensive study from Florida State University (FSU) finds no evidence to support the idea that personality changes begin before the clinical onset of mild cognitive impairment (MCI) or dementia. MCI is an intermediate...
On the evening of Monday November 27th, join us for conversation and cocktails with award-winning journalist, editor and author Tina Brown, and Indigo’s CEO Heather Reisman. Hear from Tina Brown about her eight-year tenure at Vanity...
The presence of TAR DNA-binding protein 43 (TDP-43) in the hippocampus on postmortem examination is associated with increased rates of hippocampal atrophy in patients with Alzheimer’s disease (AD), new research suggests. This association was greatest...
The material presented through the Think Tank feature on this website is in no way intended to replace professional medical care or attention by a qualified practitioner. WBHI strongly advises all questioners and viewers using this feature with health problems to consult a qualified physician, especially before starting any treatment. The materials provided on this website cannot and should not be used as a basis for diagnosis or choice of treatment. The materials are not exhaustive and cannot always respect all the most recent research in all areas of medicine.